|
|
| 2022, Vol. 31(5): 483-487 DOI: 10.3760/cma.j.cn113030-20201207-00590 | ||
| Progress on basic research and clinical application of hyperthermia combined with immune checkpoint inhibitors | ||
| Liu Pengyuan1, Wu Yajun2, Wu Zhibing3 | ||
| 1The Second Clinical Medical College of Zhejiang Chinese Medical University,Hangzhou 310053,China; 2TCM Dispensary, Affiliated Zhejiang Hospital of Zhejiang University School of Medicine, Hangzhou 310030,China; 3Department of Oncology, Affiliated Zhejiang Hospital of Zhejiang University School of Medicine, Hangzhou 310030,China |
||
| Received 2020-12-07 Revised null | ||
| Supporting info | ||
| null | ||
|
